SULT1A1 Gene: Sulfotransferase Family 1A Member 1

A key phase II drug-metabolizing enzyme involved in the sulfation of xenobiotics, hormones, and neurotransmitters.

Gene Information Card

Symbol SULT1A1
Full Name Sulfotransferase Family 1A Member 1
Gene Type protein-coding
Chromosomal Location 16p11.2
NCBI Gene ID 6817 ncbi.nlm.nih.gov/gene/6817
Ensembl ID ENSG00000196502
UniProt ID P50225
OMIM ID 171150
HGNC ID 11453
Aliases P-PST, ST1A1, ST1A3, HAST1, HAST2, TSPST1

Description

SULT1A1 encodes a member of the sulfotransferase family, which catalyzes the sulfate conjugation of many endogenous and exogenous compounds, including hormones, neurotransmitters, drugs, and dietary xenobiotics. This phase II metabolic reaction typically increases water solubility and facilitates excretion, but can also produce reactive metabolites implicated in carcinogenesis. The gene exhibits genetic polymorphisms that influence enzyme activity and are associated with altered drug response and cancer risk.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Breast Cancer Altered SULT1A1 activity may affect estrogen sulfation and DNA adduct formation; polymorphisms linked to risk PMID: 15642720, ClinVar
Colorectal Cancer Reduced sulfation of dietary procarcinogens (e.g., heterocyclic amines) may increase mutagenesis PMID: 15642720, COSMIC
Bladder Cancer Polymorphisms in SULT1A1 associated with altered risk, possibly via sulfation of aromatic amines PMID: 15642720
Acute Myeloid Leukemia Low-activity SULT1A1 variants linked to increased risk, possibly due to impaired detoxification PMID: 15642720

Expression Profile

Tissue Expression
Tissue nTPM level
Liver 28.2 High
Adrenal Gland 15.3 Medium
Small Intestine 12.1 Medium
Kidney 8.5 Medium
Lung 4.2 Low
Breast 3.1 Low
Colon 2.8 Low
Cell Line Expression
Cell Line nTPM Notes
HepG2 12.5 Hepatocellular carcinoma cell line
Caco-2 8.3 Colorectal adenocarcinoma cell line
MCF-7 4.1 Breast cancer cell line
A549 2.9 Lung carcinoma cell line
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.638A>G (p.Asn213Ser) SNP ~30% in Caucasians Reduced enzyme activity; altered drug and hormone metabolism
c.661G>A (p.Val221Met) SNP <1% Unknown functional effect
c.164A>G (p.Asn55Ser) SNP ~5% in Asians Reduced activity
c.1129G>A (p.Gly377Ser) SNP <1% Unknown functional effect
Mutation functional classification

Loss of Function (LOF)

The c.638A>G (p.Asn213Ser) variant is a common loss-of-function polymorphism resulting in reduced sulfotransferase activity.

Gain of Function (GOF)

No well-characterized gain-of-function mutations reported in SULT1A1.

Dominant Negative (DN)

No dominant-negative mutations described for SULT1A1.

Pathways

Sulfation of hormones and neurotransmitters (Reactome: R-HSA-174403)
Phase II conjugation of xenobiotics (Reactome: R-HSA-156580)
Estrogen metabolism (KEGG: hsa04915)

Protein Summary

SULT1A1 is a 295-amino acid cytosolic sulfotransferase that transfers a sulfo group from 3'-phosphoadenosine-5'-phosphosulfate (PAPS) to a hydroxyl or amine acceptor. It is highly expressed in liver and adrenal gland, and plays a critical role in the metabolism of estrogens, thyroid hormones, catecholamines, and numerous drugs and dietary compounds. Genetic polymorphisms, particularly the common Asn213Ser variant, significantly alter enzyme activity and have been linked to interindividual differences in drug response and cancer susceptibility.

Related Products

Product name Cat.No. Species Gene ID
SULT1A1 Knockout HEK293 Cell Line EDJ-KQ5864 Human 6817 Details Get a Quote
SULT1A1 Knockout A-549 Cell Line EDJ-KQ29348 Human 6817 Details Get a Quote
SULT1A1 Knockout HCT 116 Cell Line EDJ-KQ29349 Human 6817 Details Get a Quote
SULT1A1 Knockout HeLa Cell Line EDJ-KQ29350 Human 6817 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: